BTC $64,906.95 +1.22%
ETH $1,820.62 +1.34%
BNB $593.02 +1.27%
XRP $0.9698 +2.40%
SOL $73.66 +4.28%
TRX $0.3055 +0.75%
DOGE $0.0593 +2.14%
ADA $0.1545 +2.72%
BCH $211.58 +3.83%
LINK $9.30 +2.66%
HYPE $69.62 +6.89%
AAVE $114.04 +5.55%
SUI $0.7367 +3.63%
XLM $0.1407 +2.96%
ZEC $945.66 +9.97%
AAPL $352.12 -1.64%
AMZN $258.95 -2.42%
GOOGL $283.55 -3.72%
MSFT $516.54 -1.58%
META $622.51 -2.37%
NVDA $157.84 -0.45%
TSLA $381.12 -1.34%
SNDK $823.00 -0.95%
INTC $55.07 -2.67%
SPCX $138.78 -0.25%
MU $732.14 -0.36%
AMD $514.97 +1.68%
BTC $64,906.95 +1.22%
ETH $1,820.62 +1.34%
BNB $593.02 +1.27%
XRP $0.9698 +2.40%
SOL $73.66 +4.28%
TRX $0.3055 +0.75%
DOGE $0.0593 +2.14%
ADA $0.1545 +2.72%
BCH $211.58 +3.83%
LINK $9.30 +2.66%
HYPE $69.62 +6.89%
AAVE $114.04 +5.55%
SUI $0.7367 +3.63%
XLM $0.1407 +2.96%
ZEC $945.66 +9.97%
AAPL $352.12 -1.64%
AMZN $258.95 -2.42%
GOOGL $283.55 -3.72%
MSFT $516.54 -1.58%
META $622.51 -2.37%
NVDA $157.84 -0.45%
TSLA $381.12 -1.34%
SNDK $823.00 -0.95%
INTC $55.07 -2.67%
SPCX $138.78 -0.25%
MU $732.14 -0.36%
AMD $514.97 +1.68%

以色列臨床階段免疫治療公司 Enlivex Therapeutics 宣布購買比特幣作為公司資產儲備

2024-11-21 19:42:33

ChainCatcher 消息,以色列臨床階段免疫治療公司 Enlivex Therapeutics 宣布其董事會批准將最多 100 萬美元用於購買比特幣,作為現金管理策略的一部分。

該公司在美國納斯達克上市(代碼:ENLV),CEO Oren Hershkovitz 表示,隨著比特幣需求和接受度的增長,加之近期比特幣 ETF 的批准和機構投資者的支持,公司認為比特幣可以作為強有力的資產儲備,提供價值存儲和抗通脹功能。

鏈捕手ChainCatcher提醒,請廣大讀者理性看待區塊鏈,切實提高風險意識,警惕各類虛擬代幣發行與炒作,站內所有內容僅係市場信息或相關方觀點,不構成任何形式投資建議。如發現站內內容含敏感信息,可點擊,我們會及時處理。

app_icon
ChainCatcher 與創新者共建Web3世界